In the study, epidemiologists from the Universities of Exeter and Bristol in the UK, compared death rates among people infected with the new variant of Coronavirus...
In a press briefing, Peter Daszak, the president of the New York based group, EcoHealth Alliance, estimated that collective scientific research might be able to pin...
According to experts, to be able to squeeze vaccine development timelines down to 100 days, researchers would need to exploit the capabilities of rapid response platform...
According to NITI Aayog member (Health) V K Paul, in districts where COVID-19 cases are seemingly on the rise, vaccination of eligible individuals should be intensified...
According to the World Health Organisation, SARS-CoV-2 virus variants: B.1.1.7, B.1. 351 and P. 1 are the three variants of coronavirus that have been detected so...
The Central government has been ramping up the Covid-19 vaccination drive across states as it started the next phase of vaccination from March 1
Bharat Biotech's vaccine showed significantly higher neutralizing antibody responses in Phase II than in Phase I due to the difference in dosing regimens, researchers said in...
The central government has asked states to encourage registration for COVID-19 vaccination over 'walk-in' mode, to facilitate the process by making it more convenient for the...
For the study, published by the New England Journal of Medicine on Monday (March 8), researchers at Pfizer, BioNTech and the University of Texas Medical Branch...
A high-level meeting held to review the status and progress of COVID-19 vaccination across states and Union Territories (UTs) was attended by Chief Secretaries and the...
Chief Economist of the International Monetary Fund (IMF) said that while the country was hit hard by the pandemic, it stands out in terms of its...
In the phase 2 trial, the Bharat Biotech-ICMR’s COVID-19 vaccine showed better reactogenicity and safety outcomes, and enhanced humoral and cell-mediated immune responses compared with the...